The expansion of targetable biomarkers for CAR T cell therapy

MH Townsend, G Shrestha, RA Robison… - Journal of Experimental & …, 2018 - Springer
Biomarkers are an integral part of cancer management due to their use in risk assessment,
screening, differential diagnosis, prognosis, prediction of response to treatment, and …

Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker

KK Jagarlamudi, M Shaw - Biomarkers in medicine, 2018 - Taylor & Francis
Thymidine kinase 1 (TK1) is a key enzyme in DNA precursor synthesis. It is upregulated
during the S phase of the cell cycle and its presence in cells is an indicator of active cell …

Re-discovery of pyrimidine salvage as target in cancer therapy

M Walter, P Herr - Cells, 2022 - mdpi.com
Nucleotides are synthesized through two distinct pathways: de novo synthesis and
nucleoside salvage. Whereas the de novo pathway synthesizes nucleotides from amino …

Neutrophil extracellular traps accelerate vascular smooth muscle cell proliferation via Akt/CDKN1b/TK1 accompanying with the occurrence of hypertension

X Fang, L Ma, Y Wang, F Ren, Y Yu, Z Yuan… - Journal of …, 2022 - journals.lww.com
Objective: Neutrophil extracellular traps (NETs) can trigger pathological changes in vascular
cells or vessel wall components, which are vascular pathological changes of hypertension …

[HTML][HTML] Inhibition of JAK2/STAT3 signaling pathway suppresses proliferation of Burkitt's lymphoma Raji cells via cell cycle progression, apoptosis, and oxidative stress …

NW Xu, Y Chen, YJ Chen, ZM Fan, M Liu… - … Medical Journal of …, 2018 - ncbi.nlm.nih.gov
Inhibition of JAK2/STAT3 Signaling Pathway Suppresses Proliferation of Burkitt’s
Lymphoma Raji Cells via Cell Cycle Progression, Apoptosis, and Oxidative Stress by …

Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies

EG Weagel, W Burrup, R Kovtun, EJ Velazquez… - Cancer Cell …, 2018 - Springer
Background Lung, breast, and colorectal malignancies are the leading cause of cancer-
related deaths in the world causing over 2.8 million cancer-related deaths yearly. Despite …

[HTML][HTML] Increased levels of thymidine kinase 1 in malignant cell-derived extracellular vesicles

EM Doulabi, L Dubois, L Löf, TK Sinha… - … and Biophysics Reports, 2024 - Elsevier
Extracellular vesicles (EVs), whose main subtypes are exosomes, microparticles, and
apoptotic bodies, are secreted by all cells and harbor biomolecules such as DNA, RNA, and …

[HTML][HTML] Overexpression and surface localization of HPRT in prostate cancer provides a potential target for cancer specific antibody mediated cellular cytotoxicity

MH Townsend, KB Bennion, EE Bitter… - Experimental cell …, 2021 - Elsevier
We chose to evaluate Hypoxanthine Guanine Phosphoribosyltransferase (HPRT) as a
possible biomarker for prostate cancer due to its involvement in nucleotide synthesis and …

Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cells

EJ Velazquez, TD Brindley, G Shrestha, EE Bitter… - Cancer Cell …, 2020 - Springer
Abstract Background Thymidine kinase 1 (TK1) is a pyrimidine salvage pathway enzyme
that is up-regulated in malignant tissues and elevated in the serum of cancer patients. While …

[PDF][PDF] TK1 与LDH 联合检测对非霍奇金淋巴瘤鉴别诊断及疗效评估的作用

崔朝杰, 邱旸, 郝莹莹, 刘义庆, 田文君… - 现代生物医学 …, 2019 - biomed.cnjournals.com
摘要目的: 探讨联合检测血清胸苷激酶1 (TK1) 与乳酸脱氢酶(LDH) 水平在非霍奇金淋巴瘤(NHL
) 患者鉴别诊断及疗效监测中的临床意义. 方法: 收集2016 年1 月至2018 年6 月我院诊治的111 …